Addressing challenges in developing a core domain set in adherence interventions in rheumatology: A report from the OMERACT-Adherence Group

Ayano Kelly*, Susan J. Bartlett, Maarten P. De Wit, Dorcas E. Beaton, Therese Dawson, Vicki Evans, Michael Gill, Geraldine Hassett, Lyn March, Marieke Scholte-Voshaar, Jasvinder A. Singh, Allison Tong, Peter Tugwell, Peter Wong, Kathleen Tymms

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)
1 Downloads (Pure)

Abstract

Objective. The OMERACT-Adherence meeting was convened to discuss the conceptual and methodological challenges in developing a core domain set (Adherence-CDS) for trials of interventions for medication adherence in rheumatology. Methods. Forty participants from nine countries participated. Results. Four ideas emerged: for adherence trials, the Adherence-CDS could include adherence and the condition-specific CDS; many factors affect adherence and are intervention targets, contextual factors, or outcome domains; adherence is a critical factor in drug trials; and standardized adherence measures are needed. Conclusion. Despite the challenges, the meeting clarified an approach to developing an Adherence-CDS that complements existing OMERACT work and methodology.

Original languageEnglish
Pages (from-to)1202-1206
Number of pages5
JournalJournal of rheumatology
Volume46
Issue number9
DOIs
Publication statusPublished - 1 Sept 2019

Keywords

  • Omeract
  • Outcome assessment (healthcare)
  • Rheumatic diseases
  • Treatment adherence and compliance
  • n/a OA procedure

Fingerprint

Dive into the research topics of 'Addressing challenges in developing a core domain set in adherence interventions in rheumatology: A report from the OMERACT-Adherence Group'. Together they form a unique fingerprint.

Cite this